110 related articles for article (PubMed ID: 29693336)
1. Serum CXCL12, but not CXCR4, Is Associated with Head and Neck Squamous Cell Carcinomas.
Lavaee F; Zare S; Mojtahedi Z; Malekzadeh M; Khademi B; Ghaderi A
Asian Pac J Cancer Prev; 2018 Apr; 19(4):901-904. PubMed ID: 29693336
[TBL] [Abstract][Full Text] [Related]
2. CXCL12 and CXCR4, but not CXCR7, are primarily expressed by the stroma in head and neck squamous cell carcinoma.
Clatot F; Cornic M; Berghian A; Marchand V; Choussy O; El Ouakif F; François A; Ruminy P; Laberge-Le-Couteulx S; Picquenot JM; Jardin F
Pathology; 2015 Jan; 47(1):45-50. PubMed ID: 25474514
[TBL] [Abstract][Full Text] [Related]
3. SDF-1-CXCR4 axis: cell trafficking in the cancer stem cell niche of head and neck squamous cell carcinoma.
Faber A; Goessler UR; Hoermann K; Schultz JD; Umbreit C; Stern-Straeter J
Oncol Rep; 2013 Jun; 29(6):2325-31. PubMed ID: 23563306
[TBL] [Abstract][Full Text] [Related]
4. Expression of the CXCL12/CXCR4 chemokine axis predicts regional control in head and neck squamous cell carcinoma.
León X; Diez S; García J; Lop J; Sumarroca A; Quer M; Camacho M
Eur Arch Otorhinolaryngol; 2016 Dec; 273(12):4525-4533. PubMed ID: 27328961
[TBL] [Abstract][Full Text] [Related]
5. CXCR4-mediated adhesion and MMP-9 secretion in head and neck squamous cell carcinoma.
Samara GJ; Lawrence DM; Chiarelli CJ; Valentino MD; Lyubsky S; Zucker S; Vaday GG
Cancer Lett; 2004 Oct; 214(2):231-41. PubMed ID: 15363550
[TBL] [Abstract][Full Text] [Related]
6. Focus on the role of the CXCL12/CXCR4 chemokine axis in head and neck squamous cell carcinoma.
Albert S; Riveiro ME; Halimi C; Hourseau M; Couvelard A; Serova M; Barry B; Raymond E; Faivre S
Head Neck; 2013 Dec; 35(12):1819-28. PubMed ID: 23468253
[TBL] [Abstract][Full Text] [Related]
7. The Serum Concentrations of Chemokine CXCL12 and Its Specific Receptor CXCR4 in Patients with Esophageal Cancer.
Łukaszewicz-Zając M; Mroczko B; Kozłowski M; Szmitkowski M
Dis Markers; 2016; 2016():7963895. PubMed ID: 27041792
[TBL] [Abstract][Full Text] [Related]
8. Involvement of CXCL12 and CXCR4 in lymph node metastases and development of oral squamous cell carcinomas.
Oliveira-Neto HH; Silva ET; Leles CR; Mendonça EF; Alencar Rde C; Silva TA; Batista AC
Tumour Biol; 2008; 29(4):262-71. PubMed ID: 18781098
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of CXCL12 and CXCR4 in inoperable head and neck squamous cell carcinoma.
Rave-Fränk M; Tehrany N; Kitz J; Leu M; Weber HE; Burfeind P; Schliephake H; Canis M; Beissbarth T; Reichardt HM; Wolff HA
Strahlenther Onkol; 2016 Jan; 192(1):47-54. PubMed ID: 26374452
[TBL] [Abstract][Full Text] [Related]
10. SDF-1/CXCR4 expression is an independent negative prognostic biomarker in patients with head and neck cancer after primary radiochemotherapy.
De-Colle C; Menegakis A; Mönnich D; Welz S; Boeke S; Sipos B; Fend F; Mauz PS; Tinhofer I; Budach V; Abu Jawad J; Stuschke M; Balermpas P; Rödel C; Grosu AL; Abdollahi A; Debus J; Belka C; Ganswindt U; Pigorsch S; Combs SE; Lohaus F; Linge A; Krause M; Baumann M; Zips D;
Radiother Oncol; 2018 Jan; 126(1):125-131. PubMed ID: 29061496
[TBL] [Abstract][Full Text] [Related]
11. Intratumoural level of SDF-1 correlates with survival in head and neck squamous cell carcinoma.
Clatot F; Picquenot JM; Choussy O; Gouérant S; Moldovan C; Schultheis D; Cornic M; François A; Blot E; Laberge-Le-Couteulx S
Oral Oncol; 2011 Nov; 47(11):1062-8. PubMed ID: 21840752
[TBL] [Abstract][Full Text] [Related]
12. Serum stromal-derived-factor-1 (CXCL12) and its alpha chemokine receptor (CXCR4) as biomarkers in neonatal sepsis.
Badr HS; El-Gendy FM; Helwa MA
J Matern Fetal Neonatal Med; 2018 Aug; 31(16):2209-2215. PubMed ID: 28562124
[TBL] [Abstract][Full Text] [Related]
13. Construction of a CXCL12-KDEL fusion gene to inhibit head and neck squamous cell carcinoma metastasis by intracellular sequestration of CXCR4.
Zhang W; Wang X; Yue K; Liu S; Liu X
Biomed Res Int; 2015; 2015():195828. PubMed ID: 25866764
[TBL] [Abstract][Full Text] [Related]
14. Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma.
Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Hanazono K; Owaki T; Aikou T
Oncol Rep; 2009 Jan; 21(1):65-71. PubMed ID: 19082444
[TBL] [Abstract][Full Text] [Related]
15. CXCL12/CXCR4 promotes laryngeal and hypopharyngeal squamous cell carcinoma metastasis through MMP-13-dependent invasion via the ERK1/2/AP-1 pathway.
Tan CT; Chu CY; Lu YC; Chang CC; Lin BR; Wu HH; Liu HL; Cha ST; Prakash E; Ko JY; Kuo ML
Carcinogenesis; 2008 Aug; 29(8):1519-27. PubMed ID: 18487224
[TBL] [Abstract][Full Text] [Related]
16. Expression of CXCL12/CXCR4 and its correlation to prognosis in esophageal squamous cell carcinoma.
Wang DF; Lou N; Zeng CG; Zhang X; Chen FJ
Ai Zheng; 2009 Feb; 28(2):154-8. PubMed ID: 19550128
[TBL] [Abstract][Full Text] [Related]
17. CXCL12 and CXCR4 in the Peripheral Blood of Patients with Parkinson's Disease.
Bagheri V; Khorramdelazad H; Hassanshahi G; Moghadam-Ahmadi A; Vakilian A
Neuroimmunomodulation; 2018; 25(4):201-205. PubMed ID: 30428473
[TBL] [Abstract][Full Text] [Related]
18. The clinicopathological significance of the expression of CXCR4 protein in oral squamous cell carcinoma.
Almofti A; Uchida D; Begum NM; Tomizuka Y; Iga H; Yoshida H; Sato M
Int J Oncol; 2004 Jul; 25(1):65-71. PubMed ID: 15201990
[TBL] [Abstract][Full Text] [Related]
19. Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma.
Katayama A; Ogino T; Bandoh N; Nonaka S; Harabuchi Y
Clin Cancer Res; 2005 Apr; 11(8):2937-46. PubMed ID: 15837745
[TBL] [Abstract][Full Text] [Related]
20. Functional effects of SDF-1α on a CD44(+) CXCR4(+) squamous cell carcinoma cell line as a model for interactions in the cancer stem cell niche.
Faber A; Hoermann K; Stern-Straeter J; Schultz DJ; Goessler UR
Oncol Rep; 2013 Feb; 29(2):579-84. PubMed ID: 23232503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
